Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by (18)F-FDG PET/CT: A case report

RATIONALE: The case reported the rapid remission of disease recurrence achieved adding foscarnet, a DNA polymerase inhibitor that interacts with fibroblast growth factor 2, to low molecular weight heparin and sunitinib for the first time in a patient with an anaplastic thyroid cancer (ATC). PATIENT...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Medicine (Baltimore)
मुख्य लेखकों: Giannetta, Elisa, Isidori, Andrea M., Durante, Cosimo, Di Gioia, Cira, Longo, Flavia, Tombolini, Vincenzo, Bulzonetti, Nadia, Graziadio, Chiara, Pofi, Riccardo, Gianfrilli, Daniele, Verrienti, Antonella, Carletti, Raffaella, Filetti, Sebastiano, Lenzi, Andrea, Baroli, Alberto
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Wolters Kluwer Health 2017
विषय:
4300
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312981/
https://ncbi.nlm.nih.gov/pubmed/28178124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005621
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन